Neuropharmacology is the branch of pharmacology that studies drugs and their effects on the nervous system. This includes the study of neurotransmitters, which are chemical messengers in nerve cells, as well as the drugs that act on them or the neurotransmitter receptors. Neuropharmacology overlaps significantly with psychopharmacology, which is the study of how drugs affect behaviour and mood. While psychopharmacology can be considered a subfield of neuropharmacology, it also has its own theories and focus. The main goals of neuropharmacology are to understand how drugs interact with the nervous system to produce their effects, and to determine which drugs can be used to treat specific illnesses or disorders. This involves studying the effects of specific drugs on nerve cells and their receptors, as well as how drugs interact with other cellular components. Neuropharmacologists also study drug metabolism in the body, as well as interactions between the environment and drugs. Neuropharmacology is important for both the treatment of diseases and disorders of the nervous system as well as for understanding normal brain function and development. For example, neuropharmacologists can use drugs to reduce or eliminate pain, reduce seizures, improve breathing and even restore lost nerve function. Neuropharmacology is also important for understanding the effects of drugs on the brain, such as how they affect memory, concentration, learning and emotions. Different classes of drugs have specific mechanisms of action. For example, antidepressants work by changing the levels of neurotransmitters such as serotonin and norepinephrine in the brain, while cannabinoids act on cannabinoid receptors to produce their effects. Neuropharmacologists must also consider factors such as drug interactions and potential side effects. In conclusion, neuropharmacology is an important field that studies the effects of drugs on the nervous system, both in terms of disease and health. By understanding how drugs interact with the nervous system, neuropharmacologists are able to develop drugs to treat a variety of conditions, as well as to understand normal brain functions.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States